Report cover image

Global Somatropin Market Size & Share to 2027

Publisher QualiKet Research
Published Apr 29, 2022
Length 188 Pages
SKU # QUA17148382

Description

Global Somatropin Market Size & Share to 2027

Global Somatropin Market Size, Trends & Growth Opportunity, By Dosage Form (Powder, and Solvent) By Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Rental Insufficiency, Prader Willi Syndrome, SHOX Deficiency, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region and Forecast till 2027

Global Somatropin Market

Somatropinn is a human growth hormone indicated for the treatment of growth hormone deficiency in adults and children. Also, it is used for treatment of Prader-Willi syndrome, Chronic Renal Insufficiency, Turner syndrome Turner syndrome, and others. Somatropin stimulates tissue growth, and protein, lipid, carbohydrates and mineral metabolism in the body.

Market Drivers

Rise in approvals of somatropin products by regulatory authorities such as USFDA (Food and Drug Administration) is the key driving factor which is expected to boost the global somatropin market growth. For instance, in July 2018, U.S. Food and Drug Administration had approved ZOMACTON, a Somatropin injection of Ferring Pharmaceuticals Inc, for additional pediatric indications such as Idiopathic short stature (ISS), Growth failure in short stature homeobox-containing gene (SHOX) deficiency, Short stature born small for gestational age (SGA) with no catch-up growth by 2 to 4 years, and Short stature due to Turner syndrome. Furthermore, increase in prevalence of growth hormobe deficiency in children will positively contribute the market growth over the forecast period. As per article published in the Springer Nature Journal in Feb 2017, the prevalence of GHD (Growth Hormone Deficiency) in children is within range 1.8 -2.9 per 10,000 children in Europe and the U.S.

Market Restraints

However, key manufacturers are focused on developing advanced alternative treatments for growth hormone deficiency is the major challenging factor which is expected to hinder the global somatropin market growth. For instance, in October 2019, OPKO Health and Pfizer had announced the results of Phase III clinical trials, which was initiated to evaluate the efficacy and safety of somatrogen, which is long acting human growth hormone molecule administrated once in a week for growth hormone deficiency.

Market segmentation

Global Somatropin Market is segmented into dosage form such as Powder, and Solvent, by application such as Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Rental Insufficiency, Prader Willi Syndrome, SHOX Deficiency, and Others. Further, market is segmented into distribution channel such as Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

Also, Global Somatropin Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as Novo Nordisk A/S, Eli Lilly and Company, Pfizer, Inc., GeneScience Pharmaceuticals, Ipsen Inc.,Sandoz International, LG Life Sciences, Merck, Hoffmann-La Roche, and Teva Pharmaceuticals.

Market Taxonomy

By Dosage Form
  • Powder
  • Solvent
By Application
  • Growth Hormone Deficiency (GHD)
  • Turner Syndrome
  • Chronic Rental Insufficiency
  • Prader Willi Syndrome
  • SHOX Deficiency
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Questions Addressed by the Report
  • What are the Key Opportunities in Global Somatropin Market?
  • What will be the growth rate from 2019 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?
Somatropin Market,Somatropin Industry,Somatropin Market Size,Somatropin Market Share,Somatropin Market Trend,Somatropin Market Growth

Table of Contents

188 Pages
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Somatropin Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Somatropin Market, By Dosage Form
5.1 Y-o-Y Growth Comparison, By Dosage Form
5.2 Global Somatropin Market Share Analysis, By Dosage Form
5.3 Global Somatropin Market Size and Forecast, By Dosage Form
5.3.1 Powder
5.3.2 Solvent
6 Global Somatropin Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Somatropin Market Share Analysis, By Application
6.3 Global Somatropin Market Size and Forecast, By Application
6.3.1 Growth Hormone Deficiency (GHD)
6.3.2 Turner Syndrome
6.3.3 Prader Willi Syndrome
6.3.4 SHOX Deficiency
6.3.5 Others
7 Global Somatropin Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Somatropin Market Share Analysis, By Distribution Channel
7.3 Global Somatropin Market Size and Forecast, By Distribution Channel
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Online Pharmacies
8 Global Somatropin Market, By Region
8.1 Global Somatropin Market Share Analysis, By Region
8.2 Global Somatropin Market Share Analysis, By Region
8.3 Global Somatropin Market Size and Forecast, By Region
9 North America Somatropin Market Analysis and Forecast (2020-2027)
9.1 Introduction
9.2 North America Somatropin Market Share Analysis, By Dosage Form
9.3 North America Somatropin Market Size and Forecast, By Application
9.4 North America Somatropin Market Size and Forecast, By Distribution Channel
9.5 North America Somatropin Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 EuropeSomatropin Market Analysis and Forecast (2020-2027)
10.1 Introduction
10.2 Europe Somatropin Market Share Analysis, By Dosage Form
10.3 Europe Somatropin Market Size and Forecast, By Application
10.4 Europe Somatropin Market Size and Forecast, By Distribution Channel
10.5 Europe Somatropin Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Somatropin Market Analysis and Forecast (2020-2027)
11.1 Introduction
11.2 Asia Pacific Somatropin Market Share Analysis, By Dosage Form
11.3 Asia Pacific Somatropin Market Size and Forecast, By Application
11.4 Asia Pacific Somatropin Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Somatropin Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Somatropin Market Analysis and Forecast (2020-2027)
12.1 Introduction
12.2 Latin America Somatropin Market Share Analysis, By Dosage Form
12.3 Latin America Somatropin Market Size and Forecast, By Application
12.4 Latin America Somatropin Market Size and Forecast, By Distribution Channel
12.5 Latin America Somatropin Market Size and Forecast, Country
13 Middle East Somatropin Market Analysis and Forecast (2020-2027)
13.1 Introduction
13.2 Middle East Somatropin Market Share Analysis, By Dosage Form
13.3 Middle East Somatropin Market Size and Forecast, By Application
13.4 Middle East Somatropin Market Size and Forecast, By Distribution Channel
13.5 Middle East Somatropin Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Novo Nordisk A/S
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Eli Lilly and Company
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Pfizer, Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 GeneScience Pharmaceuticals
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Ipsen Inc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Sandoz International
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 LG Life Sciences
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Merck
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Hoffmann-La Roche
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Teva Pharmaceuticals
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us